Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alx Oncology Holdings (ALXO) Other Gross PP&E Adjustments (2019 - 2026)

Alx Oncology Holdings' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$21000.0 for Q4 2023.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 100.67% to -$21000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was -$21000.0, a 100.67% decrease, with the full-year FY2023 number at -$21000.0, down 100.67% from a year prior.
  • Other Gross PP&E Adjustments hit -$21000.0 in Q4 2023 for Alx Oncology Holdings, up from -$395000.0 in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for ALXO hit a ceiling of $3.2 million in Q4 2022 and a floor of -$4.7 million in Q2 2022.
  • Historically, Other Gross PP&E Adjustments has averaged -$716062.5 across 5 years, with a median of -$312500.0 in 2021.
  • The widest YoY moves for Other Gross PP&E Adjustments: up 293.68% in 2022, down 18724.0% in 2022.
  • Tracing ALXO's Other Gross PP&E Adjustments over 5 years: stood at $2.2 million in 2019, then crashed by 110.2% to -$223000.0 in 2020, then plummeted by 630.94% to -$1.6 million in 2021, then skyrocketed by 293.68% to $3.2 million in 2022, then crashed by 100.67% to -$21000.0 in 2023.
  • Business Quant data shows Other Gross PP&E Adjustments for ALXO at -$21000.0 in Q4 2023, -$395000.0 in Q3 2023, and -$587000.0 in Q2 2023.